Abstract
In this present study, we investigated the utilization of whey powder as an alternate carbon source and statistical optimization of medium components on lovastatin production by Aspergillus terreus MTCC 1281. Central composite design (CCD) of response surface methodology (RSM) was successfully employed to optimize the four medium variables whey powder, yeast extract, sodium chloride, and copper sulphate at five levels. Regression analysis explained that the linear and square effects of the variables were found significant with R 2 value of 0.937. Maximum lovastatin production of 358.2 mg/L was obtained with the predicted optimal concentration of whey powder 1.5%, yeast extract 0.75%, sodium chloride 0.04%, and copper sulphate 0.019%.The results of this study indicated that statistical optimization approach leads to high lovastatin production by using whey powder as a carbon source.
Similar content being viewed by others
References
Kosikowski FV. Whey utilization and whey products. J. Dairy Sci. 62: 1149–1160 (1979)
Gonzfilez Siso MI. The biotechnological utilization of cheese whey: A review. Bioresource Technol. 57: 1–11 (1996)
Haast JD, Britz TJ, Novellow JC. Effect of different nutrilizing treatments on the efficiency of an anaerobic digester fed with deproteinated cheese whey. J. Dairy Res. 53: 467–476 (1986)
Dragone G, Mussatto SI, Almeida e Silva JB, Teixeira JA. Optimal fermentation conditions for maximizing the ethanol production by Kluyveromyces fragilis from cheese whey powder. Biomass Bioenerg. 35: 1977–1982 (2011)
Ozmihci S, Kargi F. Fermentation of cheese whey powder solution to ethanol in a packed-column bioreactor: Effects of feed sugar concentration. J. Chem. Technol. Biot. 84: 106–111 (2009)
Ghaly AE, Kamal M, Correia LR. Kinetic modelling of continuous submerged fermentation of cheese whey for single cell protein production. Bioresource Technol. 96: 1143–1152 (2005)
Manzoni M, Rollini M. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol lowering drugs. Appl. Microbiol. Biot. 58: 555–564 (2002)
Jones KD, Couldwell WT, Hinton DR, Su YH, He SK, Anker L, Law RE. Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem. Biophys. Res. Commun. 205: 1681–1687 (1994)
Newman A, Clutterbuch RD, Powles RL, Millar JL. Selective inhibition of primary acute myeloid leukemia cell growth by lovastatin. Leukemia 8: 2022–2029 (1994)
Alberts AW, Chen J, Kurov G, Hunt V, Huff J, Hoffman C, Rothrock J, Lopez M, Joshua H, Harris E, Patchett A, Monaghan R, Currie S, Stapley E, Albers-Schonberg G, Hensens O, Hirschfield J, Hoofsteen KJ, Liesch J, Springer J. A highly potent competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase and a cholesterol-lowering agent. P. Natl. Acad. Sci. USA 77: 3957–3961 (1980)
Miyake T, Uchitomi K, Zhang MY, Kono I, Nozaki N, Sammoto H, Inagaki K. Effects of principal nutrients on lovastatin production by Monascus pilosus. Biosci. Biotech. Bioch. 70: 1154–1159 (2006)
Negishi S, Cai-Huang Z, Hasumi K, Murakawa S, Endo A. Productivity of monacolin K (Mevinolin) in the genus Monascus. J. Ferment. Eng. 64: 509–512 (1986)
Kennedy M, Krouse D. Strategies for improving fermentation medium performance: A review. J. Ind. Microbiol. Biot. 23: 456–475 (1999)
Hajjaj H, Niederberger P, Duboc P. Lovastatin biosynthesis by Aspergillus terreus in a chemically defined medium. Appl. Environ. Microb. 67: 2596–2604 (2001)
Lai LST, Hung CS, Lo CC. Effects of lactose and glucose on the production of itaconic acid and lovastatin by A. terreus ATCC 20542. J. Biosci. Bioeng. 104: 9–13 (2007)
Novak N, Gerdin S, Berovic M. Increased lovastatin formation using repeated fed-batch process. Biotechnol. Lett. 19: 947–948 (1997)
Sayyad SA, Panda BP, Ali M, Javed S. Optimization of nutrient parameters for lovastatin production by Monascus purpureus MTCC 369 under submerged fermentation using response surface methodology. Appl. Microbiol. Biot. 73: 1054–1058 (2007)
Bas D, Boyaci IH. Modeling and optimization I: Usability of response surface methodology. J. Food Eng. 78: 836–845 (2007)
Myers RH, Montgomery DC. Response Surface Methodology, Process and Product Optimization Using Design Experiments. 3rd ed. John Wiley & Sons, New York, NY, USA. pp. 19–39 (2009)
Baskar G, Renganathan S. Design of experiments and artificial neural network linked genetic algorithm for modeling and optimization of l-asparaginase production by Aspergillus terreus MTCC 1782. Biotechnol. Bioproc. E. 16: 50–58 (2011)
Baskar G, Renganathan S. Statistical and evolutionary optimisation of operating conditions for enhanced production of fungal l-asparaginase. Chem. Pap. 65: 798–804 (2011)
Casas Lopez JL, Sanchez Perez JA, Fernandez Sevilla JM, Acien Fernandez FG, Molina Grima E, Chisti Y. Fermentation optimization for the production of lovastatin by Aspergillus terreus: Use of response surface methodology. J. Chem. Technol. Biot. 79: 1119–1126 (2004)
Lai LST, Pan CC, Tzeng BK. The influence of medium design on lovastatin production and pellet formation with a high-producing mutant of Aspergillus terreus in submerged cultures. Process Biochem. 38: 1317–1326 (2003)
Chang YN, Huang JC, Lee CC, Shih IL, Tzeng YM. Use of response surface methodology to optimize medium for production of lovastatin by Monascus ruber. Enzyme Microb. Technol. 30: 889–894 (2002)
Samiee MS, Moazami N, Haghighi S, Mohseni FA, Mirdamadi S, Bakhtiari MA. Screening of lovastatin production by filamentous fungi. Iranian Biomed. J. 7: 29–33 (2003)
Haaland PD. Experimental Design in Biotechnology. Marcel Dekker, New York, NY, USA. pp. 61–83 (1989)
Muralidhar RV, Chirumamila RR, Marchant R, Nigam P. A response surface approach for the comparison of lipase production by Candida cylindracea using two different carbon sources. Biochem. Eng. J. 9: 17–23 (2001)
Szakacs G, Morovjan G, Tengerdy PR. Production of lovastatin by a wild strain of Aspergillus terreus. Biotechnol. Lett. 20: 411–415 (1998)
Rodriguez Porcel EM, Casas Lopez JL, Sanchez Perez JA, Chisti Y. Lovastatin production by Aspergillus terreus in a two-staged feeding operation. J. Chem. Technol. Biot. 83: 1236–1243 (2008)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karthika, C., Sharmila, G., Muthukumaran, C. et al. Utilization of whey powder as an alternate carbon source for production of hypocholesterolemic drug by Aspergillus terreus MTCC 1281. Food Sci Biotechnol 22, 1–7 (2013). https://doi.org/10.1007/s10068-013-0220-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10068-013-0220-8